That's the provocative question posed by Nina King, a 27-year-old Ph.D. student whose theory on the cultural impact of Ozempic—a weight-loss drug developed to treat type 2 diabetes—has gone ...
Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also increasing in popularity as weight-loss options for people around the world. When ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback